Compass Therapeutics, Inc. (CMPX)
NCM – Real Time Price. Currency in USD
2.18
-0.01 (-0.68%)
Market open: Aug 12, 2026, 12:13 PM EDT
2.21
+0.01 (0.45%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
2.18
-0.01 (-0.68%)
Market open: Aug 12, 2026, 12:13 PM EDT
2.21
+0.01 (0.45%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $35.5M significantly exceed its total debt $9.6M, ensuring strong financial flexibility
Total current assets $180.9M exceed Total current liabilities $16.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$14.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.22 | 6.05 | 10 | |
| Quick ratio | 11.22 | 5.63 | 10 | |
| Debt to Equity | 0.06 | 0.30 | 9.0 | |
| Debt to Assets | 0.05 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 850K | N/A | N/A |
| Gross Profit | -2M | -2M | -903K | -1M | -1M |
| Operating Income | -42M | -50M | -57M | -73M | -81M |
| Net Income | -39M | -42M | -49M | -66M | -73M |
| EBITDA | -40M | -48M | -55M | -71M | -80M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -49.88 | 1.0 |
| Next quarter | N/A | -45.5 | 1.0 |
| Current year | N/A | -13.75 | 1.0 |
| Next year | N/A | -6.65 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -37.32 | -29.99 | 14.05 | 5.0 |
| Y/Y | 999 | -26.51 | 7.14 | -26.04 | 4.3 |
| 3y average | 632.67 | -19.71 | -4.97 | -12.76 | 3.3 |
| 5y average | 779.2 | -37.08 | 14.21 | -15.53 | 5.0 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |